Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

被引：0
|
作者：
Gürman, G [1 ]
Üstün, C [1 ]
Arslan, O [1 ]
Beksaç, M [1 ]
Konuk, N [1 ]
Arat, M [1 ]
Celebi, H [1 ]
Özcan, M [1 ]
Ilhan, O [1 ]
Demirer, T [1 ]
Akan, H [1 ]
Uysal, A [1 ]
Koc, H [1 ]
机构：
[1] Ankara Univ, Sch Med, Ibni Sina Hosp, Dept Hematol, TR-06100 Ankara, Turkey
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4509
引用
收藏
页码：350B / 351B
页数：2
相关论文
共 50 条
  • [1] Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.
    Gürman, G
    Üstün, C
    Arslan, Ö
    Beksaç, M
    Konuk, N
    Arat, M
    Çelebi, H
    Özcan, M
    Ilhan, O
    Demirer, T
    Akan, H
    Uysal, A
    Koç, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S22 - S22
  • [2] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
    Frère, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BLOOD, 2004, 104 (11) : 355B - 355B
  • [3] Unrelated and sibling allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced hematological malignancies by using non-myeloablative conditioning regimen.
    Roemer, E
    Kiehl, MG
    Guenzelmann, S
    Rajewski, A
    Kirsten, D
    Fauser, AA
    Basara, N
    BLOOD, 2000, 96 (11) : 782A - 782A
  • [4] Allogeneic hematopoietic stem cell (HSCT) in patients with advanced hematological diseases using a non-myeloablative conditioning regimen.
    de Magalhaes-Silverman, M
    Lee, CK
    Hohl, RJ
    Masaki, H
    Schlueter, A
    Field, E
    Gingrich, RD
    BLOOD, 2000, 96 (11) : 328B - 329B
  • [5] Non-myeloablative conditioning regimen for allogeneic stem cell transplantation in patients with advanced hematological malignancies
    Malesevic, M
    Stamatovic, D
    Tukic, L
    Marjanovic, S
    Balint, B
    Tarabar, O
    Todoric, B
    Ristic, L
    Milicevic, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S294 - S295
  • [6] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    Frère, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 411 - 418
  • [7] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    P Frère
    F Baron
    C Bonnet
    K Hafraoui
    M Pereira
    E Willems
    G Fillet
    Y Beguin
    Bone Marrow Transplantation, 2006, 37 : 411 - 418
  • [8] Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine
    Carella, AM
    HEMATOLOGY JOURNAL, 2004, 5 : S68 - S75
  • [9] Allogeneic and matched unrelated donor hematopoietic stem cell transplantation (HSCT) for hematologic malignancies using a modified reduced intensity conditioning regimen.
    Raflores, M
    Rossetti, J
    Lister, J
    Shadduck, R
    Lech, J
    Kaplan, R
    Kennedy, M
    Schunn, G
    BLOOD, 2005, 106 (11) : 416B - 416B
  • [10] Long Term Outcome of Patients Receiving Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Haematologic Malignancies
    Tang, Si Ying
    Linn, Yeh Ching
    Tai, Bee Choo
    Poon, Michelle L. M.
    Tan, Lip Kun
    Tan, Belinda
    Lim, Yelly
    Soh, Teck Guan
    Ramos, Davanaliz Gonzales
    Hwang, William Y. K.
    Koh, Liang Piu
    BONE MARROW TRANSPLANTATION, 2018, 53 : 279 - 279
12345